Evonik Evonik

X

CAS 56961-75-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 56961-75-2
Also known as: 56961-75-2, Benzaldehyde, 2,3,5-trichloro-, Schembl189844, Dtxsid3069146, Djyrztclvdkwbl-uhfffaoysa-, Zinc2539407
Molecular Formula
C7H3Cl3O
Molecular Weight
209.5  g/mol
InChI Key
DJYRZTCLVDKWBL-UHFFFAOYSA-N

1 2D Structure

CAS 56961-75-2

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2,3,5-trichlorobenzaldehyde
2.1.2 InChI
InChI=1S/C7H3Cl3O/c8-5-1-4(3-11)7(10)6(9)2-5/h1-3H
2.1.3 InChI Key
DJYRZTCLVDKWBL-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C1=C(C=C(C(=C1C=O)Cl)Cl)Cl
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 56961-75-2

2. Benzaldehyde, 2,3,5-trichloro-

3. Schembl189844

4. Dtxsid3069146

5. Djyrztclvdkwbl-uhfffaoysa-

6. Zinc2539407

7. 2,3,5-trichlorobenzaldehyde, 98%

8. Cl8240

9. Mfcd00010860

10. Akos005254300

11. Cs-w021478

12. Ds-2628

13. Ac-25650

14. Db-019675

15. Ft-0609445

16. T1182

17. 3,3-bis(4-chlorophenyl)pyrrolidine-2,5-dione

18. 961t752

2.3 Create Date
2005-03-27
3 Chemical and Physical Properties
Molecular Weight 209.5 g/mol
Molecular Formula C7H3Cl3O
XLogP33.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count1
Rotatable Bond Count1
Exact Mass207.924948 g/mol
Monoisotopic Mass207.924948 g/mol
Topological Polar Surface Area17.1 Ų
Heavy Atom Count11
Formal Charge0
Complexity151
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag Poland
Digital Content Digital Content
56961-75-2
2,3,5-trichlorobenzaldehyde
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's bigge...
Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY